GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Linc AB (OSTO:LINC) » Definitions » Notes Receivable

Linc AB (OSTO:LINC) Notes Receivable : kr0.00 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Linc AB Notes Receivable?

Linc AB's Notes Receivable for the quarter that ended in Mar. 2025 was kr0.00 Mil.


Linc AB Notes Receivable Historical Data

The historical data trend for Linc AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Linc AB Notes Receivable Chart

Linc AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Notes Receivable
Get a 7-Day Free Trial - - - - -

Linc AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Linc AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Linc AB Notes Receivable Related Terms

Thank you for viewing the detailed overview of Linc AB's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Linc AB Business Description

Traded in Other Exchanges
N/A
Address
Strandvagen 7A, Stockholm, SWE, 114 51
Linc AB is an investor in product-oriented companies in the Nordic Life Science industry. It mainly invests in and develops small and medium-sized product-oriented life science companies in medical technology and pharmaceuticals.